Tradestie Institutional Equity Comparison Engine

AURA vs TYRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AURA Overall Edge

AURA Captures Institutional Edge (2โ€“1 Pillars ยท 1โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aura Biosciences, Inc. Common Stock (AURA) driven by superior Momentum & Technical, Options & Structure while TYRA counters with relative strength in Growth & Margin. Fundamentally, AURA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus TYRA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AURA sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro) against TYRA sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AURA N/M vs TYRA N/M Fwd P/E
Growth & Margin Winner TYRA
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner AURA
1Y +30.4% vs +26.8% ยท 52W Pos 52% vs 20%
Options & Structure Winner AURA
CONSOLIDATION (22nd %ile IV) vs BREAKDOWN (3rd %ile IV)
AURA NASDAQ
Aura Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$7.21
+1.41% 1D
Market Cap $728.6M
1M Return +18.2%
1Y Return +30.38%
Forward P/E N/M
Unified AI Score
31.1 / 100 SELL
Tech 8.0 Fund 39.0 Flow 71.0 Mom 44.0
TYRA NASDAQ
Tyra Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$19.77
-1.27% 1D
Market Cap $1.3B
1M Return +6.75%
1Y Return +26.81%
Forward P/E N/M
Unified AI Score
33.0 / 100 SELL
Tech 25.0 Fund 46.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AURA +30.38% TYRA +26.81% Spread: +3.57 pp (AURA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AURA TTM Op. Margin: 0.0% TYRA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AURA vs TYRA. Trailing 12-month operating profitability (AURA 0.0% vs TYRA 0.0%) and valuation multiples (AURA N/M vs TYRA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AURA (1) vs TYRA (4)
Institutional Metric AURA TYRA Criterion Row Winner
Market Capitalization Scale $728.6M $1.3B Larger Scale TYRA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -61.7% -34.9% Higher ROE TYRA
52-Week Range Position Momentum 52% ($5โ€“$10) 20% ($15โ€“$41) Stronger Trend AURA
Beta / 30D Volatility Risk Regime 0.92ฮฒ ยท 75% Vol 0.79ฮฒ ยท 49% Vol Lower Realized Risk TYRA
Unified Institutional Score Composite Signal 31.1 / 100 (SELL) 33.0 / 100 (SELL) Higher Composite TYRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AURA vs TYRA Buy Guide
AURA CONSOLIDATION
135d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live AURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TYRA BREAKDOWN
76d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live TYRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AURA nor TYRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.